Harringtonine

Overview

No overview information available.

No background information available.

用于治疗急性粒细胞白血病、急性单核细胞性白血病，对骨髓增生不良综合征（MDS）、真性红细胞增多症、慢性粒细胞性白血病亦有一定的疗效。

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor

No clinical trials found for this drug

Product Name	Manufacturer	Route	Strength	Approved	NDC Code

No FDA products found for this drug

Medicine Name	EMA Number	Auth. Holder	Country	Drug Type	Status	Issued	Opinion	Revision

No EMA products found for this drug

Product Name	Manufacturer	Dosage Form	Strength	Approved	Approval No.

No Singapore products found for this drug

Product Name	Approval No.	Manufacturer	Dosage Form	Trade Name	Strength	Type	Status	Date	Import
Harringtoninie Injection	国药准字H50021997	重庆药友制药有限责任公司	注射剂	N/A	2ml:2mg	Chemical Drug	Approved	2020/09/30	Domestic
Harringtonine Injection	国药准字H33022218	杭州民生药业集团有限公司	N/A	N/A	1ml:1mg	Chemical Drug	Approved	2003/04/18	Domestic
Harringtonine Injection	国药准字H33022219	杭州民生药业集团有限公司	N/A	N/A	2ml:2mg	Chemical Drug	Approved	2003/04/18	Domestic
Harringtonine Injection	国药准字H11022037	北京协和药厂有限公司	注射剂（小容量注射剂）	N/A	1ml:1mg	Chemical Drug	Approved	2022/07/20	Domestic
Harringtoninie Injection	国药准字H50021998	重庆药友制药有限责任公司	注射剂	N/A	1ml:1mg	Chemical Drug	Approved	2020/09/30	Domestic
Harringtoninie Injection	国药准字H14022720	山西国润制药有限公司	注射剂	N/A	1ml:1mg	Chemical Drug	Approved	2020/08/05	Domestic
Harringtonine Injection	国药准字H35021234	福州海王福药制药有限公司	注射剂	N/A	1ml:1mg	Chemical Drug	Approved	2021/02/19	Domestic

Product Name	ARTG ID	Sponsor	Status	Reg. Date	Ingredient

No Australia products found for this drug

No news found